Impel Pharmaceuticals
Michael Malafronte brings to Impel NeuroPharma over 30 years of executive experience with quality systems and operations within the medical device and pharmaceutical industry. Prior to joining Impel NeuroPharma, Michael was Senior Director of Quality at Nitto Denko Technical based in San Diego. Michael previously directed quality groups at Quorum Review IRB, Nitto Denko Technical, Theravance, Nastech Pharmaceuticals, and ICOS Corporation.
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.